From: A possible case of bictegravir-associated severe unconjugated hyperbilirubinemia
Three months before admission | On admission | Day 3 | 3 weeks later | 2 months later | Reference values | |
---|---|---|---|---|---|---|
WBC (K/uL) | 5.20 | 7.41 | 6.46 | 6.82 | 6.5 | 4.5–5.2 |
Hemoglobin (g/dl) | 15.5 | 16.1 | 12.1 | 11.7 | 16.3 | 13–16 |
Platelets (K/uL) | 194 | 188 | 163 | 166 | 157 | 163–667 |
MCV (fl) | 90.1 | 89.9 | 101.4 | 102 | 95.6 | 78–98 |
Reticulocyte % | 4.83 | 0.5–1.8 | ||||
Total bilirubin (mg/dL) | 2.1 | 17.2 | 11.2 | 4.3 | 2.8 | 0–1 |
Direct bilirubin (mg/dL) | 0.3 | 1 | 0.5 | 0.2 | 0–0.2 | |
Indirect bilirubin (mg/dL) | 16.2 | 10.7 | 4.1 | 0.1–1.1 | ||
ALP (IU/L) | 81 | 55 | 45 | 63 | 70 | 35–129 |
ALT (IU/L) | 16 | 16 | 18 | 13 | 39 | 5–41 |
AST (IU/L) | 19 | 19 | 18 | 18 | 33 | 5–37 |
LDH (U/L) | 205 | 135–225 | ||||
Folate (ng/ml) | 7.4 | |||||
TSH (mcIU/ml) | 0.64 | 0.27–4.2 | ||||
Vitamin B12 (pg/ml) | 303 | 232–1425 | ||||
HIV RNA PCR copies/ml | 93 | 426 | ||||
CD4% | 32 | 21 | 31–59 | |||
CD8% | 44 | 53 | 13–37 | |||
ABO/Rh | O positive | |||||
Haptoglobin (mg/dL) | < 8 | 43–212 | ||||
Hepatitis A Virus,© Ig G | Reactive | |||||
Hepatitis A Virus, IgM | Non-Reactive | |||||
Hepatitis B Surface Ag | Non-Reactive | |||||
Hepatitis B Surface Ab | Positive | |||||
Hepatitis B Core Ab IgG | Non-Reactive | |||||
Hepatitis C Ab IgG | Non-Reactive |